This value represents the intracellular equivalent of an apparent binding affinity as measured by inhibitory constant, Ki, and is determined using a cellular target engagement CETSA HT assay following compound incubation with prostate-cancer derived cells endogenously expressing AR. Here, AR is linked to prostate cancer.